137 related articles for article (PubMed ID: 7516887)
1. Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro: comparison with normal blast cells.
Tohyama K; Ueda T; Yoshida Y; Nakamura T
Exp Hematol; 1994 Jul; 22(7):539-45. PubMed ID: 7516887
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of myelodysplastic syndromes with cytokines].
Tohyama K; Ueda T; Tsutani H; Wano Y; Nakamura T
Rinsho Ketsueki; 1993 Mar; 34(3):277-82. PubMed ID: 8479078
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
Nagler A; Ginzton N; Negrin R; Bang D; Donlon T; Greenberg P
Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
[TBL] [Abstract][Full Text] [Related]
4. Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: response to individual colony-stimulating factors.
Sawada K; Sato N; Tarumi T; Sakai N; Koizumi K; Sakurama S; Ieko M; Yasukouchi T; Koyanagawa Y; Yamaguchi M
Br J Haematol; 1993 Mar; 83(3):349-58. PubMed ID: 7683482
[TBL] [Abstract][Full Text] [Related]
5. Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: II. Response to combined colony-stimulating factors.
Sawada K; Sato N; Notoya A; Tarumi T; Yasukouchi T; Yamaguchi M; Kohno M; Mikuni C; Koike T
Eur J Haematol; 1995 Feb; 54(2):85-94. PubMed ID: 7535245
[TBL] [Abstract][Full Text] [Related]
6. Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.
Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B
Cancer Res; 1993 Jan; 53(2):401-9. PubMed ID: 7678076
[TBL] [Abstract][Full Text] [Related]
7. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of G-CSFR and GM-CSFR expressions on CD34+ cells in patients with aplastic anemia and myelodysplastic syndrome.
Xu H; Li A; Yu Y; Li J; Liu X; Wang X; Wang X; Xu G
Int J Lab Hematol; 2009 Dec; 31(6):597-602. PubMed ID: 18637807
[TBL] [Abstract][Full Text] [Related]
10. Transitional changes in immunophenotypic subpopulations of human peripheral blood CD34+ cells expanded in vitro.
Koizumi K; Sawada K; Sato N; Hirayama S; Yasukouchi T; Yamaguchi M; Takahashi TA; Sekiguchi S; Koike T
Exp Hematol; 1994 Nov; 22(12):1171-8. PubMed ID: 7523169
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
12. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
13. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.
Gidáli J; Fehér I; Hollán SR
Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498
[TBL] [Abstract][Full Text] [Related]
14. The use of haemopoietic growth factors in the treatment of myelodysplastic syndromes.
Greenberg PL; Negrin R; Nagler A
Cancer Surv; 1990; 9(1):199-212. PubMed ID: 2276114
[TBL] [Abstract][Full Text] [Related]
15. [In vitro effects of hematopoietic growth factors on CD34+ cell from patients with myelodysplastic syndromes].
Yang X; Gu X; Pei X; Zhu L
Zhonghua Xue Ye Xue Za Zhi; 1997 Jul; 18(7):354-7. PubMed ID: 15624331
[TBL] [Abstract][Full Text] [Related]
16. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
Chen G; Shao Z; Jia H
Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
[TBL] [Abstract][Full Text] [Related]
17. [Importance of GM-CSF for in vitro cytogenetic bone marrow analysis in patients with myelodysplastic syndrome].
Karásková J; Holena O; Michalová K
Cas Lek Cesk; 1997 Oct; 136(20):633-7. PubMed ID: 9490208
[TBL] [Abstract][Full Text] [Related]
18. [In vitro growth and clinical response of leukemia cells to macrophage colony-stimulating factor (M-CSF) and granulocyte colony-stimulating factor (G-CSF) in acute leukemia].
Takeyama H; Kajiguchi T; Miyata Y; Saito M
Gan To Kagaku Ryoho; 2000 Jun; 27(6):873-8. PubMed ID: 10897214
[TBL] [Abstract][Full Text] [Related]
19. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
20. In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34 cells.
Rigolin GM; Porta MD; Ciccone M; Bugli AM; Bragotti LZ; Mauro E; Fraulini C; Rossi AR; Bardi A; Cuneo A; Castoldi G
Br J Haematol; 2004 Aug; 126(4):501-7. PubMed ID: 15287942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
